Insulin activates the kinase activity of the Raf-1 proto-oncogene by increasing its serine phosphorylation. 1990

K S Kovacina, and K Yonezawa, and D L Brautigan, and N K Tonks, and U R Rapp, and R A Roth
Department of Pharmacology, Stanford University School of Medicine, California 94305-5332.

Insulin was found to stimulate the serine/threonine kinase activity of the proto-oncogene product Raf-1. This stimulation was observed in HeLa, NIH 3T3, and Chinese hamster ovary cells, all overexpressing the human insulin receptor. In the HeLa cells, 100 pM insulin gave a significant increase in Raf-1 kinase activity, and 100 nM insulin caused a maximal 2-5-fold increase in activity. The increase in activity was detected after 2 min of insulin treatment and peaked after 5 min. In addition to stimulating Raf-1 kinase activity, insulin caused a shift in the electrophoretic mobility of the Raf-1 protein and an increase in the amount of serine phosphorylation of Raf-1. Moreover, a serine/threonine-specific phosphatase, phosphatase 1, but not two tyrosine-specific phosphatases, was found to deactivate the insulin-activated Raf-1 kinase activity. These findings indicate that insulin activates the serine/threonine kinase activity of the Raf-1 proto-oncogene by increasing its content of phosphoserine.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D010768 Phosphoserine The phosphoric acid ester of serine. Serine Phosphate,Phosphorylserine,Seryl Phosphate,Phosphate, Serine,Phosphate, Seryl
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell

Related Publications

K S Kovacina, and K Yonezawa, and D L Brautigan, and N K Tonks, and U R Rapp, and R A Roth
October 1990, Biochemical and biophysical research communications,
K S Kovacina, and K Yonezawa, and D L Brautigan, and N K Tonks, and U R Rapp, and R A Roth
July 1990, The Journal of biological chemistry,
K S Kovacina, and K Yonezawa, and D L Brautigan, and N K Tonks, and U R Rapp, and R A Roth
January 1994, The Journal of biological chemistry,
K S Kovacina, and K Yonezawa, and D L Brautigan, and N K Tonks, and U R Rapp, and R A Roth
July 1993, Nature,
K S Kovacina, and K Yonezawa, and D L Brautigan, and N K Tonks, and U R Rapp, and R A Roth
December 2004, Science (New York, N.Y.),
K S Kovacina, and K Yonezawa, and D L Brautigan, and N K Tonks, and U R Rapp, and R A Roth
November 1998, Nature,
K S Kovacina, and K Yonezawa, and D L Brautigan, and N K Tonks, and U R Rapp, and R A Roth
January 2024, Journal of biomolecular structure & dynamics,
K S Kovacina, and K Yonezawa, and D L Brautigan, and N K Tonks, and U R Rapp, and R A Roth
May 2002, Molecular and cellular biology,
K S Kovacina, and K Yonezawa, and D L Brautigan, and N K Tonks, and U R Rapp, and R A Roth
February 2015, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
K S Kovacina, and K Yonezawa, and D L Brautigan, and N K Tonks, and U R Rapp, and R A Roth
December 1993, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!